Veru Inc. Share Price
NASDAQ: VERU | Micro CapVeru Inc. Stock Performance
Veru Inc. Share Price Today
As of 30 October 2026, Veru Inc.'s share price is $2.23. The stock opened at $2.26, compared to its previous close of $2.27. During today's trading session, Veru Inc.'s share price traded between $2.22 and $2.28, with an average price of $2.25. Over the past 52 weeks, the stock has recorded a high of $7.23 and a low of $2.06. In terms of performance, Veru Inc.'s share price has declined by 1.11% over the last six months and is down 24.62% on a year-on-year basis.
Veru Inc. Share Price Chart
Veru Inc. Quarterly Profit & Loss
All figures in USD
Veru Inc. Annual Profit & Loss
All figures in USD
About Veru Inc.
Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.
Veru Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $2.61 | $2.24 | -16.26% |
Sep 2026 | $2.82 | $2.67 | -2.73% |
Aug 2026 | $2.26 | $2.75 | +23.04% |
Jul 2026 | $3.15 | $2.23 | -28.82% |
Jun 2026 | $2.28 | $3.14 | +33.33% |
May 2026 | $2.26 | $2.35 | +4.20% |
Apr 2026 | $2.30 | $2.26 | +1.35% |
Mar 2026 | $2.50 | $2.23 | -12.55% |
Feb 2026 | $2.54 | $2.55 | +0.79% |
Jan 2026 | $2.18 | $2.53 | +18.78% |
Dec 2025 | $2.48 | $2.13 | -14.11% |
Nov 2025 | $2.95 | $2.48 | -16.36% |